Patents by Inventor Fabrice Viviani

Fabrice Viviani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040082610
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) in which R1a is hydrogen, halogen, hydroxyl, amino, alkylamino, dialkylamino, hydroxyamino, alkoxyamino or alkylalkoxyamino and R1b is hydrogen, or R1a and R1b form an oxo, R2 is carboxyl, carboxymethyl or hydroxymethyl, R3 is alkyl either substituted with phenylthio optionally substituted with halogen, hydroxyl, alkyl, alkoxy, trifluoromethyl, trifluoromethoxy, carboxyl, alkoxycarbonyl, cyano or amino, or with cycloalkylthio (3 to 7 members) optionally substituted with halogen or trifluoromethyl, or with heteroarylthio (5 to 6 members and 1 to 4 heteroatoms chosen from N, O and S), optionally substituted with halogen, hydroxyl, alkyl, alkoxy, trifluoromethyl, trifluoromethoxy, carboxyl, alkoxycarbonyl, cyano or amino or R3 is propargyl substituted with phenyl or heteroaryl as defined above, R4 is alkyl, alkenyl-CH2— or alkynyl-CH2—, cycloalkyl or cycloalkylalkyl, in their various isomeric forms, separate or as mixtures, and also their sa
    Type: Application
    Filed: September 10, 2003
    Publication date: April 29, 2004
    Inventors: Eric Bacque, Antony Bigot, Youssef El Ahmad, Jean-Luc Malleron, Serge Mignani, Baptiste Ronan, Michel Tabart, Fabrice Viviani
  • Publication number: 20030171369
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Application
    Filed: March 14, 2003
    Publication date: September 11, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Eric Bacque, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michael Evers, Fabrice Viviani, Youssef El Ahmad, Stephane Mutti
  • Patent number: 6602884
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Bacqué, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michel Evers, Fabrice Viviani, Youssef El Ahmad, Stéphane Mutti, Christophe Daubié
  • Patent number: 6603005
    Abstract: Heterocyclylalkylpiperidine derivatives of general formula (I) in their enantiomeric or diastereoisomeric forms or mixtures of these forms, and/or, where appropriate, in their syn or anti form or a mixture thereof, as well as any salt thereof.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Baque, Jean-Christophe Carry, Youssef El-Ahmad, Michel Evers, Philippe Hubert, Jean-Luc Malleron, Serge Mignani, Guy Pantel, Michel Tabart, Fabrice Viviani
  • Publication number: 20020177606
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Application
    Filed: March 13, 2002
    Publication date: November 28, 2002
    Inventors: Eric Bacque, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michel Evers, Fabrice Viviani, Youssef El Ahmad, Stephane Mutti, Christophe Daubie
  • Publication number: 20020111492
    Abstract: Heterocyclylalkylpiperidine derivatives of general formula (I) 1
    Type: Application
    Filed: November 14, 2001
    Publication date: August 15, 2002
    Inventors: Eric Baque, Jean-Christophe Carry, Youssef El-Ahmad, Michel Evers, Philippe Hubert, Jean-Luc Malleron, Serge Mignani, Guy Pantel, Michel Tabart, Fabrice Viviani
  • Patent number: 6403610
    Abstract: Quinolylpropylpiperidine derivatives of formula (I) which are particularly advantageous antimicrobial agents, their compositions, and their use.
    Type: Grant
    Filed: September 18, 2000
    Date of Patent: June 11, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Luc Malleron, Michel Tabart, Jean-Christophe Carry, Michel Evers, Youssef El Ahmad, Serge Mignani, Fabrice Viviani, Michel Cheve